TPA, NCPA Applaud Tennessee Law Banning PBMs From Owning Pharmacies

Why It Matters

By separating PBMs from pharmacy ownership, the law aims to reduce drug‑price manipulation and protect independent pharmacists, potentially reshaping the U.S. pharmacy market.

Key Takeaways

• Tennessee joins Arkansas in banning PBM‑owned pharmacies
• PBMs spent >$7 M and 60+ lobbyists to block the bill
• TPA and NCPA hail the law as a patient‑protection win
• Law forces PBMs to choose: manage benefits or run pharmacies
• Federal bill reintroduced to require national PBM‑pharmacy divestiture

Pulse Analysis

The FAIR Rx Act reflects a growing backlash against the vertical integration of pharmacy benefit managers and retail pharmacies. Critics argue that when a PBM controls both the formulary and the dispensing outlet, it can steer patients toward higher‑priced drugs and siphon rebates, inflating out‑of‑pocket costs. Tennessee’s move, backed by the state’s pharmacists association, seeks to restore market competition by ensuring independent pharmacies can negotiate on a level playing field without the shadow of a dominant PBM owner.

Beyond Tennessee, the legislation signals a broader regulatory trend. Arkansas enacted a similar ban last year, and a federal bill reintroduced in May would compel any company that owns a health insurer or PBM to divest its pharmacy operations. If passed, the federal measure could create a nationwide standard, prompting industry consolidation strategies to shift toward pure‑play PBMs or separate pharmacy chains. Stakeholders are watching closely, as compliance costs and strategic realignments could reshape profit models across the healthcare supply chain.

For patients and payers, the expected outcome is greater price transparency and potentially lower drug costs. Independent pharmacies, which serve as critical access points in rural and underserved communities, may experience renewed growth and bargaining power. However, the transition could also trigger short‑term disruptions as PBMs restructure their business units. Overall, the Tennessee law adds momentum to a policy wave that could redefine how prescription benefits are managed and delivered across the United States.